| ID Source | ID |
|---|---|
| PubMed CID | 122198 |
| MeSH ID | M0059948 |
| Synonym |
|---|
| 63346-83-8 |
| adeturon |
| s-2-aminoethyl-isothiuronium adenosine triphosphate |
| DTXSID90979478 |
| 2-aminoethyl carbamimidothioate--9-[5-o-(hydroxy{[hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl)pentofuranosyl]-9h-purin-6-amine (1/1) |
| 2-aminoethyl carbamimidothioate;[[(2r,3s,4r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Adeturon was shown to produce a pronounced protective effect on DNA synthesis progressively inhibited by the doses applied." | ( [Effect of adeturon on postradiation macromolecular synthesis in the peripheral blood leukocytes of gamma ray-irradiated rats]. Marinova, Ts; Pantev, T, ) | 1.24 |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Adeturone pretreatment provided slight protection to rat spleen and mouse bone marrow; by day 10, however, both animal species exhibited a vigorous proliferative response of nucleated cells in the bone marrow, which resulted in 75% survival rate among animals exposed to a lethal radiation dose." | ( Adeturone protection of hemopoiesis in lethally irradiated mice and rats. Minkova, MI; Pantev, TP, 1988) | 2.44 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 12 (92.31) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (6.25%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 30 (93.75%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||